Infection in Solid Organ Transplant Recipients clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)
Sorry, in progress, not accepting new patients
The purpose of this study is to determine the safety and long-term immunogenicity of the 13-Valent Pneumococcal Conjugate vaccine in children who are solid organ transplant recipients.
at UCLA
Our lead scientists for Infection in Solid Organ Transplant Recipients research studies include Jaime G Deville, MD, FAAP.
Last updated: